Literature DB >> 10396238

Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: a study of 121 cases.

K Kurian1, A al-Nafussi.   

Abstract

AIMS: To examine the relation between invasive adenocarcinoma and its alleged precursor, cervical glandular intraepithelial neoplasia (CGIN), and to assess the management and outcome of CGIN and the validity of using the term "microinvasive adenocarcinoma."
METHODS: The clinical and pathological features of 121 cases of glandular neoplasia of the cervix diagnosed between the years 1990 to 1995 were examined for the following: histological diagnosis, smear records, type of treatment, the association between the precursor lesions and invasive disease, and follow up.
RESULTS: 27 cases were identified as low grade CGIN (L-CGIN) and 38 as high grade CGIN (H-CGIN), 10 as microinvasive adenocarcinoma (less than 5 mm in depth), and 46 as invasive adenocarcinoma. The ratio of non-invasive to invasive disease was 1.12:1. The mean age of women was 39, 43, 43, and 48 years for L-CGIN, H-CGIN, microinvasive, and invasive adenocarcinoma, respectively. L-CGIN was seen in 13% and 18% of H-CGIN and microinvasive disease, respectively. H-CGIN was seen in 100% of microinvasive and 26% of invasive adenocarcinomas. The available smears before diagnosis predicted 59% of L-CGIN, 70% of H-CIGN, 100% of microinvasive adenocarcinoma, and 32% of invasive adenocarcinomas. Treatment of 74% of L-CGIN, 52% of H-CIGN, and 10% of microinvasive adenocarcinoma was by diathermy loop excision only. The remaining cases had hysterectomy. Residual disease was found in 43%, 50%, and 33% of hysterectomies for L-CGIN, H-CGIN, and microinvasive adenocarcinoma, respectively. This is correlated with positive margins, or disease within 3 mm of margins on loop specimens. Cervical smear follow up for two to seven years revealed no recurrence of glandular lesions in any of the cases of CGIN or microinvasive adenocarcinoma.
CONCLUSIONS: Precursor glandular lesions tend to progress to invasive carcinoma. There is a progressive increase in age of patients from L-CGIN to invasive disease, a span of approximately 10 years. There is a high association between H-CGIN and invasive disease. In the management of such alleged precursors, it is important to ensure adequate free margins of at least 3 mm. Microinvasive adenocarcinoma appears to have an excellent prognosis if treated by hysterectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10396238      PMCID: PMC501054          DOI: 10.1136/jcp.52.2.112

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  44 in total

1.  Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia). A correlative study of 23 cases with histologic grading, histochemical analysis of mucins, and immunohistochemical determination of the affinity for four lectins.

Authors:  E Gloor; J Hurlimann
Journal:  Cancer       Date:  1986-09-15       Impact factor: 6.860

2.  Morphology of adenocarcinoma in situ of the uterine cervix: a study of 14 cases.

Authors:  E Gloor; J Ruzicka
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

3.  A retrospective review of adenocarcinoma-in-situ and glandular atypia of the uterine cervix.

Authors:  D M Luesley; J A Jordan; C B Woodman; N Watson; D R Williams; C Waddell
Journal:  Br J Obstet Gynaecol       Date:  1987-07

4.  In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases.

Authors:  A H Qizilbash
Journal:  Am J Clin Pathol       Date:  1975-08       Impact factor: 2.493

5.  Adenocarcinoma in situ of the cervix: an underdiagnosed lesion.

Authors:  M E Boon; J P Baak; P J Kurver; S H Overdiep; G W Verdonk
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

6.  Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis.

Authors:  S Teshima; Y Shimosato; K Kishi; T Kasamatsu; K Ohmi; Y Uei
Journal:  Cancer       Date:  1985-07-01       Impact factor: 6.860

7.  Adenocarcinoma of the uterine cervix: cytological evidence of a long preclinical evolution.

Authors:  M M Boddington; A I Spriggs; R H Cowdell
Journal:  Br J Obstet Gynaecol       Date:  1976-11

8.  Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri.

Authors:  W M Christopherson; N Nealon; L A Gray
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

9.  Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions.

Authors:  L Bousfield; F Pacey; Q Young; I Krumins; R Osborn
Journal:  Acta Cytol       Date:  1980 Jul-Aug       Impact factor: 2.319

10.  Adenocarcinoma in situ of the cervix.

Authors:  A G Ostör; R Pagano; R A Davoren; D W Fortune; W Chanen; R Rome
Journal:  Int J Gynecol Pathol       Date:  1984       Impact factor: 2.762

View more
  6 in total

1.  Cervical intraepithelial glandular neoplasia.

Authors:  M K Heatley
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

2.  Effect of using templates on the information included in histopathology reports on specimens of uterine cervix taken by loop excision of the transformation zone.

Authors:  W A Reid; A I al-Nafussi; G Rebello; A R Williams
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

Review 3.  [Precancerous lesions of the uterine cervix: morphology and molecular pathology].

Authors:  L-C Horn; K Klostermann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 4.  Endocervical glandular lesions: controversial aspects and ancillary techniques.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

5.  Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix.

Authors:  Isao Murakami; Takuma Fujii; Kaori Kameyama; Takashi Iwata; Miyuki Saito; Kaneyuki Kubushiro; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

6.  Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.

Authors:  H P van de Nieuwenhof; L F A G Massuger; J A de Hullu; M A P C van Ham; J A A M van Dijck; A G Siebers; R L M Bekkers
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.